LONG-DES VI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LONG-DES VI, covering 2017-02-24 to 2017-02-24. Get the full timeline:
Most recent: Clinical Trial Update: LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) [Phase 4]